Edition:
India

Canopy Growth Corp (WEED.TO)

WEED.TO on Toronto Stock Exchange

46.32CAD
1:30am IST
Change (% chg)

$-0.29 (-0.62%)
Prev Close
$46.61
Open
$46.81
Day's High
$47.30
Day's Low
$46.23
Volume
1,001,966
Avg. Vol
2,195,535
52-wk High
$76.68
52-wk Low
$31.81

Summary

Name Age Since Current Position

John Bell

2019 Independent Chairman of the Board

Mark Zekulin

2019 President, Chief Executive Officer

Mike Lee

2019 Acting Chief Financial Officer

Rade Kovacevic

2017 Senior Vice President, Managing Director

Olivier Dufourmantelle

2017 Senior Vice President - Strategic Expansion and Continuous Improvement

Mark Ware

2018 Chief Medical Officer

Murray Goldman

2015 Independent Director

Chris Schnarr

2014 Independent Director

Peter Stringham

2016 Independent Director

Biographies

Name Description

John Bell

Mr. John K. Bell FCPA, FCA, ICD.D,, serves as Independent Chairman of the Board of the Company. He is founded Shred-Tech and grew it into a global giant in the mobile document shredding and recycling industry. After selling Shred-Tech in 1995, he purchased Polymer Technologies and grew it from a local plastics manufacturer to a global auto parts company before exiting in 2007. John also served as interim CEO and director of ATS Automation (TSX), which operates 24 global manufacturing facilities, has 4,000 employees and $700 million in sales during a time of management and board renewal in 2007. John was the lead investor and Chairman of BSM Wireless (TSX-V). First investing in 2006, he led board and management renewal leading to substantial and profitable growth before successfully exiting in 2014. John also sits on the Board of Strongco Corp, traded on the Toronto Stock Exchange as SQP and DelMar Pharmaceuticals, which is traded on OTCQX as DMPI.

Mark Zekulin

Mr. Mark Zekulin is President, Chief Executive Officer of the Company. He is the President of Tweed Inc. He is the President of Tweed Inc. He ensures that patients and healthcare practitioners choose Tweed as their trusted supplier of marijuana for medical purposes. This includes overseeing Tweed’s medical and patient outreach strategy, driving Tweed’s operations and advancing Tweed’s market strategy. He is also Tweed’s Senior and Responsible Person in Charge under the Marihuana for Medical Purposes Regulations. A graduate from the University of Waterloo in Mathematics, the University of Ottawa in Law, and the University of Cambridge in International Law, Mark has previously kept himself busy providing legal, political and strategic advice to high- profile local and international corporate clients, most recently as Counsel at the Ottawa-Washington international trade law firm of Cassidy Levy Kent. Previously, Mark has also served as a Senior Advisor to the Honourable Dwight Duncan, the Ontario Minister of Finance, and has worked internationally at the Business and Industry Advisory Committee to the Organization for Economic Co-operation and Development (OECD) as Acting Senior Policy Manager.

Mike Lee

Mr. Mike Lee is Acting Chief Financial Officer of the Company. Mike brings a wealth of experience from the consumer goods & beverages industry, having worked for companies such as E. & J. Gallo Winery, PepsiCo, and recently Constellation Brands, where he served as Senior Vice President & CFO for theirUS$3BWine & Spirits Division. He worked closely with Constellation Brands' executive leadership to transform their premium Wine & Spirits business, applying financial rigor along the way with a true sense of urgency that translated strategy into action. Mike also led the business transformation agenda at Constellation Brands, focused on digital enablement and operating model design. Most recently, Mike has served in the role of Executive Vice President, Finance at Canopy Growth Corporation.

Rade Kovacevic

Olivier Dufourmantelle

Mark Ware

Dr. Mark Ware is Chief Medical Officer of the Company. Dr. Ware is an associate professor of family medicine and anesthesia at McGill University. Over a period of 20 years he has established himself as a dedicated researcher and thought leader in advancing the medical community's understanding of cannabis and cannabinoids. His research has focused on the safety, efficacy and effectiveness of cannabis and cannabinoids in pain and symptom management, and dates back well before the days of commercial cannabis production. He served for 10 years as executive director of the non-profit Canadian Consortium for the Investigation of Cannabinoids (CCIC), and is also a long-standing board member of the International Association for Cannabinoid Medicines. In 2016, Dr. Ware served as vice-chair of the government of Canada's Task Force on Cannabis Legalization and Regulation. Dr. Ware will take a leave of absence from McGill University to pursue this opportunity.

Murray Goldman

Mr. Murray A. Goldman, Ph.D., is Independent Director of the company. He is the former Chairman of Bedrocan Canada Inc. and joined the Board of Directors when Bedrocan was successfully acquired by Canopy Growth. Mr. Goldman is the founder and Chairman of The Goldman Group, a fully integrated real estate development company that has developed and built in Canada, the United States and Israel for over 50 years. The company has a history of innovative and original mixed-use developments that have established precedent- setting neighbourhoods in the Greater Toronto Area. In 2010, Mr. Goldman received the NAIOP lifetime achievement award acknowledging his leadership in this field. Mr. Goldman continues to serve as a director of a number of prominent organizations and is a major investor and founder of a number of innovative medical and scientific research companies.

Chris Schnarr

Mr. Chris Schnarr serves as Independent Director of the company. He is the Chief Financial Officer at Delivra Inc., a company involved in the development and sale of transdermal products and technologies for the topical delivery of pharmaceutical and natural molecules. Mr. Schnarr has 25 years of experience founding, managing, and advising growth companies, including strategy, corporate finance, capital markets, corporate development, M&A, financial reporting, and governance. His functional experience across executive positions spans Treasurer, Executive Vice President, Chief Financial Officer, President, and Chief Executive Officer. His broad industry experience includes technology (hardware, software, and services), communications, agriculture, food processing and food ingredients, financial services, health care, and sustainability. Mr. Schnarr has 18-years of public company Board experience across TSXV and TSX listed companies, as well as extensive committee experience. He is presently a Director and Chair of the Audit Committee and member of the Governance and Compensation Committees of Legumex Walker Inc. (TSX:LWP). Mr. Schnarr holds a Masters in Business Administration (finance) from University of British Columbia (1990), and a Bachelor of Business Administration degree with a Minor in Economics, from Wilfrid Laurier University (1989). He is a member of the Institute of Corporate Directors, a graduate of the Directors Education Program at the Rotman School of Business at the University of Toronto, and holds the ICD.D designation.

Peter Stringham

Mr. Peter E. Stringham is Independent Director of the Company. Mr. Peter E. Stringham retired in 2016 as Chairman and Chief Executive Officer of The Young & Rubicam Group of Companies. Mr. Stringham served as the Chief Executive Officer of Young & Rubicam Brands at Young & Rubicam, Inc. since March 2, 2007. Mr. Stringham served as Group General Manager of Marketing of HSBC Holdings PLC. and HSBC Bank plc. since 2001. He served as Head of Global Marketing for HSBC Holdings plc. until March 2007. He joined HSBC in 2001 and served for 6 years, where he was instrumental in positioning it as the ‘world’s local bank’ in a series of local advertising and marketing campaigns and has helped build HSBC into one of the world’s most recognized brands. .

Basic Compensation

Name Fiscal Year Total

John Bell

270,900

Mark Zekulin

2,496,580

Mike Lee

--

Rade Kovacevic

2,147,730

Olivier Dufourmantelle

720,298

Mark Ware

--

Murray Goldman

150,000

Chris Schnarr

190,000

Peter Stringham

160,750
As Of  31 Mar 2018